SCHEMBL8668658

SCHEMBL8668658

CNc1cccc(C[CH]c2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
HTR6 P50406 3/20 0.36
APP P05067 1/20 0.36
MAOB P27338 3/20 0.35
MAOA P21397 2/20 0.35
HDAC4 P56524 1/20 0.35
MEF2D Q14814 1/20 0.35
MAPT P10636 4/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP3A4 P08684 1/20 0.34
NPC1 O15118 1/20 0.33
RECQL P46063 1/20 0.33
RAB9A P51151 1/20 0.33
ATM Q13315 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GAA P10253 1/20 0.33
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8555266 0.82 HDAC4 (0.41) TSHRHDAC4MEF2DMAPTKDM4E
SCHEMBL8671683 0.81 ALDH1A1 (0.52) HTR6MAOBMAOAHDAC4MEF2D
SCHEMBL12838129 0.78 TSHR (0.39) TSHRHTR6APPHDAC4MAPT
SCHEMBL12707605 0.77 TSHR (0.54) TSHRHTR6APPMAPTKDM4E
SCHEMBL8560494 0.77 HDAC4 (0.35) HDAC4MEF2DSMN1; SMN2ALDH1A1
SCHEMBL28387332 0.77 ALDH1A1 (0.42) TSHRAPPMAPTKDM4ECYP3A4
SCHEMBL25659414 0.75 APP (0.37) TSHRHTR6APPMAOBHDAC4
SCHEMBL18905641 0.75 TSHR (0.48) TSHRHTR6APPMAPTKDM4E
SCHEMBL69726 0.74 MAOB (0.57) TSHRMAOBMAOACYP3A4TAAR1
SCHEMBL7047409 0.74 TSHR (0.42) TSHRHTR6APPHDAC4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed